Send the following on WhatsApp
Continue to Chathttps://nl.marketscreener.com/koers/aandeel/AMRYT-PHARMA-PLC-66481723/nieuws/Amryt-presenteert-gegevens-van-OPTIMAL-en-MPOWERED-fase-3-proeven-open-label-verlenging-van-Mycapss-40689351/?utm_source=whatsapp&utm_medium=social&utm_campaign=share